Peer AI, a leading agentic AI platform for life sciences regulatory documentation, has appointed David Florez as Vice President of Sales. Florez will lead go-to-market strategy, drive enterprise adoption of AI-powered regulatory intelligence, and focus on building strong customer relationships to support successful change management as organizations transition from AI pilots to full-scale production across regulatory workflows.
“AI implementation requires world-class technology and governance, validation, change management, and organizational alignment to drive change,” said Anita Modi, CEO and co-founder of Peer AI. “David has deep life sciences expertise and proven go-to-market success helping customers navigate transitions during major waves of technology innovation. As more companies embrace the shift to an intelligent regulatory workflow, David’s experience will be instrumental in driving customer success and helping Peer AI enter its next phase of growth.”
The life sciences sector is rapidly moving beyond AI experimentation to production-scale deployment in critical regulatory workflows. Peer AI’s agentic platform combines specialized AI agents with an intuitive interface, allowing medical writers to apply subject-matter expertise at key control points while automating repetitive drafting tasks. This results in faster timelines, higher document quality, and reduced operational burden across pre-clinical, clinical, regulatory affairs, and CMC functions.
Florez’s extensive experience scaling mission-critical cloud solutions in highly regulated environments positions him to accelerate Peer AI’s enterprise adoption. His track record includes partnering with pharma and biotech leaders to implement transformative technology, ensuring alignment with compliance, validation, and organizational change requirements.
“Being a true partner means being where the industry is headed,” said David Florez, Vice President of Sales at Peer AI. “I’ve seen companies struggle with the same documentation bottlenecks, even with the world’s best content and data management systems. Regulatory documentation slows drug development down. It’s an area ripe for change and Peer AI is leading the way. I’m committed to helping the industry experience the value of agentic AI and move to a new frontier in how this critical work gets done.”
Florez and the Peer AI team will exhibit at the DIA Regulatory Submissions, Information, and Document Management (RSIDM) Forum, February 2-4, 2026. Attendees can experience live demos of the platform and schedule meetings to explore how agentic AI modernizes regulatory documentation workflows.
About Peer AI
Peer AI transforms regulatory documentation for life sciences companies through specialized AI agents that reduce drafting time. The agentic AI platform automates document creation across protocols, clinical study reports (CSR), narratives, investigational new drug (IND) applications, investigator’s brochures (IBs), and plain language summaries, while medical writers maintain oversight and control. Peer AI serves pharmaceutical, biotech, and CRO organizations worldwide. The company is backed by top investors and led by industry veterans with decades of experience in AI and life sciences.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.